Skip Nav Destination
Effects of Low-Dose ‘Factor VIII Inhibitor Bypassing Activity (FEIBA)’ in Resistant Haemophilia
Acta Haematol (1980) 64 (1): 12–17.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data
- Matteo Rota
- Paolo A. Cortesi
- Roberto Crea
- Alessandro Gringeri
- Lorenzo G. Mantovani
Blood Advances (2017) 1 (26): 2637.
Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression
- M. J. TREUR
- F. MCCRACKEN
- B. HEEG
- A. V. JOSHI
- M. F. BOTTEMAN
- F. DE CHARRO
- B. VAN HOUT
Haemophilia (2009) 15 (2): 420.
The Role of Prothrombin Complex Concentrates In the Treatment of Hemophiliacs with Factor VIII Inhibitors
- J. M. Lusher
Scandinavian Journal of Haematology (2009) 33 (S40): 195.